Marrone Bio Innovations, Inc.

Marrone Bio Innovations, Inc.

MBII
Marrone Bio Innovations, Inc.US flagNASDAQ Capital Market
0.80
USD
-0.20
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Pamela G. Marrone
Full Time Employees
153
Sector
Basic Materials
Industry
Agricultural Inputs
Address
1540 Drew Ave Davis CA United States of America 27617
IPO Date
Aug 2, 2013
Business
Marrone Bio Innovations, Inc. discovers, develops, produces, and commercializes biological products for pest management, plant nutrition, and plant health for agricultural, turf, ornamental, and water treatment applications globally. Its core product portfolio includes bioinsecticides such as Grandevo and Venerate, biofungicides, bionematicides including Majestene, bioherbicides, plant health enhancers like Haven and Pacesetter, and microbial-based products such as Regalia, Stargus, Zelto, Jet-Ag, Jet-Oxide, and Zequanox which target pests, diseases, and waterway algae control while promoting sustainable crop yields. The company leverages a proprietary microbial screening technology and superior natural product chemistry, supported by over 400 issued and pending patents, and a library of more than 18,000 microorganisms and numerous plant extracts. Founded in 2006 and headquartered in Davis, California, Marrone Bio Innovations operates internationally with a focus on sustainable agriculture, serving farmers, turf managers, and consumers by offering environmentally responsible bio-based solutions that reduce reliance on synthetic chemicals and help combat pest resistance. In July 2022, Marrone Bio Innovations completed a strategic merger with Bioceres Crop Solutions Corp., becoming a wholly owned subsidiary operating under the name ProFarm. This merger integrated Marrone’s biological solutions product lineup and pipeline into Bioceres’ portfolio, expanding geographic reach to the U.S., Europe, and Latin America and optimizing operational efficiency by consolidating corporate support functions and expanding a global footprint. Following the merger, Marrone Bio Innovations discontinued its North Carolina headquarters, with operations and leadership integrated under Bioceres, enhancing its capability to deliver low environmental impact, biologically based crop protection and plant health products. Recent developments include the scheduled launch of a next-generation bioherbicide, MBI-006, expected between 2024 and 2025, targeting organic and specialty crops, turf, ornamentals, and home and garden markets. The company continues to advance a robust product pipeline comprising bioherbicides, biofumigants, nematicides, insecticides, fungicides, and plant health candidates. Marrone’s strategic alliance and operational integration with Bioceres enable it to leverage combined expertise and commercial resources to lead innovation in sustainable agricultural solutions, positioning itself as a significant player in the global $60 billion crop protection and plant health industry. The company’s dedication to biological discovery and commercialization drives continuous innovation while addressing global food security and environmental challenges.

Company News

APIChat
  • Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions

  • Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.

  • Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1

  • Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q1 2022 Results - Earnings Call Transcript

  • Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates

  • Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results

  • MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII

  • MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

  • Marrone Bio Innovations, Inc. (MBII) Reports Q4 Loss, Tops Revenue Estimates

  • Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript

  • Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results

  • Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops

  • Best Penny Stocks To Buy? 4 Agriculture & Farmings Stocks To Watch

  • SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Marrone Bio Innovations, Inc. Merger

  • MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

  • Why Is Marrone Bio Innovations (MBII) Stock Up Today?

  • Marrone Bio (MBII) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Marrone Bio Innovations, Inc. Is Fair to Shareholders

  • Marrone Bio (MBII) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Marrone Bio Innovations, Inc. Is Fair to Shareholders

  • Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement

  • Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement